keyword
MENU ▼
Read by QxMD icon Read
search

rpn13

keyword
https://www.readbyqxmd.com/read/27827410/sgta-interacts-with-the-proteasomal-ubiquitin-receptor-rpn13-via-a-carboxylate-clamp-mechanism
#1
Arjun Thapaliya, Yvonne Nyathi, Santiago Martínez-Lumbreras, Ewelina M Krysztofinska, Nicola J Evans, Isabelle L Terry, Stephen High, Rivka L Isaacson
The fate of secretory and membrane proteins that mislocalize to the cytosol is decided by a collaboration between cochaperone SGTA (small, glutamine-rich, tetratricopeptide repeat protein alpha) and the BAG6 complex, whose operation relies on multiple transient and subtly discriminated interactions with diverse binding partners. These include chaperones, membrane-targeting proteins and ubiquitination enzymes. Recently a direct interaction was discovered between SGTA and the proteasome, mediated by the intrinsic proteasomal ubiquitin receptor Rpn13...
November 9, 2016: Scientific Reports
https://www.readbyqxmd.com/read/27667482/modeling-oblong-proteins-and-water-mediated-interfaces-with-rosettadock-in-capri-rounds-28-35
#2
Nicholas A Marze, Jeliazko R Jeliazkov, Shourya Sonkar Roy Burman, Scott E Boyken, Frank DiMaio, Jeffrey J Gray
The 28th-35th rounds of the Critical Assessment of PRotein Interactions (CAPRI) served as a practical benchmark for our RosettaDock protein-protein docking protocols, highlighting strengths and weaknesses of the approach. We achieved acceptable or better quality models in three out of 11 targets. For the two α-repeat protein-green fluorescent protein (αrep-GFP) complexes, we used a novel ellipsoidal partial-global docking method (Ellipsoidal Dock) to generate models with 2.2 Å/1.5 Å interface RMSD, capturing 49%/42% of the native contacts, for the 7-/5-repeat αrep complexes...
September 26, 2016: Proteins
https://www.readbyqxmd.com/read/27396824/structures-of-rpn1-t1-rad23-and-hrpn13-hplic2-reveal-distinct-binding-mechanisms-between-substrate-receptors-and-shuttle-factors-of-the-proteasome
#3
Xiang Chen, Leah Randles, Ke Shi, Sergey G Tarasov, Hideki Aihara, Kylie J Walters
Three receptors (Rpn1/S2/PSMD2, Rpn10/S5a, Rpn13/Adrm1) in the proteasome bind substrates by interacting with conjugated ubiquitin chains and/or shuttle factors (Rad23/HR23, Dsk2/PLIC/ubiquilin, Ddi1) that carry ubiquitinated substrates to proteasomes. We solved the structure of two such receptors with their preferred shuttle factor, namely hRpn13(Pru):hPLIC2(UBL) and scRpn1 T1:scRad23(UBL). We find that ubiquitin folds in Rad23 and Dsk2 are fine-tuned by residue substitutions to achieve high affinity for Rpn1 and Rpn13, respectively...
August 2, 2016: Structure
https://www.readbyqxmd.com/read/27118409/targeting-proteasome-ubiquitin-receptor-rpn13-in-multiple-myeloma
#4
Y Song, A Ray, S Li, D S Das, Y T Tai, R D Carrasco, D Chauhan, K C Anderson
Proteasome inhibitor bortezomib is an effective therapy for relapsed and newly diagnosed multiple myeloma (MM); however, dose-limiting toxicities and the development of resistance can limit its long-term utility. Recent research has focused on targeting ubiquitin receptors upstream of 20S proteasome, with the aim of generating less toxic therapies. Here we show that 19S proteasome-associated ubiquitin receptor Rpn13 is more highly expressed in MM cells than in normal plasma cells. Rpn13-siRNA (small interfering RNA) decreases MM cell viability...
September 2016: Leukemia: Official Journal of the Leukemia Society of America, Leukemia Research Fund, U.K
https://www.readbyqxmd.com/read/26903513/major-histocompatibility-complex-mhc-class-i-processing-of-the-ny-eso-1-antigen-is-regulated-by-rpn10-and-rpn13-proteins-and-immunoproteasomes-following-non-lysine-ubiquitination
#5
Richard Golnik, Andrea Lehmann, Peter-Michael Kloetzel, Frédéric Ebstein
The supply of MHC class I-restricted peptides is primarily ensured by the degradation of intracellular proteins via the ubiquitin-proteasome system. Depending on the target and the enzymes involved, ubiquitination is a process that may dramatically vary in terms of linkages, length, and attachment sites. Here we identified the unique lysine residue at position 124 of the NY-ESO-1 cancer/testis antigen as the acceptor site for the formation of canonical Lys-48-linkages. Interestingly, a lysine-less form of NY-ESO-1 was as efficient as its wild-type counterpart in supplying the HLA-A*0201-restricted NY-ESO-1157-165 antigenic peptide...
April 15, 2016: Journal of Biological Chemistry
https://www.readbyqxmd.com/read/26466095/a-high-affinity-hrpn2-derived-peptide-that-displaces-human-rpn13-from-proteasome-in-293t-cells
#6
Xiuxiu Lu, Fen Liu, Sarah E Durham, Sergey G Tarasov, Kylie J Walters
Rpn13 is a proteasome ubiquitin receptor that has emerged as a therapeutic target for human cancers. Its ubiquitin-binding activity is confined to an N-terminal Pru (pleckstrin-like receptor for ubiquitin) domain that also docks it into the proteasome, while its C-terminal DEUBAD (DEUBiquitinase ADaptor) domain recruits deubiquitinating enzyme Uch37 to the proteasome. Bis-benzylidine piperidone derivatives that were found to bind covalently to Rpn13 C88 caused the accumulation of polyubiquitinated proteins as well as ER stress-related apoptosis in various cancer cell lines, including bortezomib-resistant multiple myeloma lines...
2015: PloS One
https://www.readbyqxmd.com/read/26450923/rpn10-monoubiquitination-orchestrates-the-association-of-the-ubiquilin-type-dsk2-receptor-with-the-proteasome
#7
Alice Zuin, Anne Bichmann, Marta Isasa, Pilar Puig-Sàrries, Luís Miguel Díaz, Bernat Crosas
Despite the progress made in understanding the roles of proteasome polyubiquitin receptors, such as the subunits Rpn10 (regulatory particle non-ATPase 10) and Rpn13, and the transient interactors Rad23 (radiation sensitivity abnormal 23) and Dsk2 (dual-specificity protein kinase 2), the mechanisms involved in their regulation are virtually unknown. Rpn10, which is found in the cell in proteasome-bound and -unbound pools, interacts with Dsk2, and this interaction has been proposed to regulate the amount of Dsk2 that gains access to the proteasome...
December 15, 2015: Biochemical Journal
https://www.readbyqxmd.com/read/26222436/redundant-roles-of-rpn10-and-rpn13-in-recognition-of-ubiquitinated-proteins-and-cellular-homeostasis
#8
Jun Hamazaki, Shoshiro Hirayama, Shigeo Murata
Intracellular proteins tagged with ubiquitin chains are targeted to the 26S proteasome for degradation. The two subunits, Rpn10 and Rpn13, function as ubiquitin receptors of the proteasome. However, differences in roles between Rpn10 and Rpn13 in mammals remains to be understood. We analyzed mice deficient for Rpn13 and Rpn10. Liver-specific deletion of either Rpn10 or Rpn13 showed only modest impairment, but simultaneous loss of both caused severe liver injury accompanied by massive accumulation of ubiquitin conjugates, which was recovered by re-expression of either Rpn10 or Rpn13...
July 2015: PLoS Genetics
https://www.readbyqxmd.com/read/26202105/protein-expression-of-proteasome-subunits-in-elderly-patients-with-schizophrenia
#9
Madeline R Scott, Maria D Rubio, Vahram Haroutunian, James H Meador-Woodruff
The ubiquitin proteasome system (UPS) is a major regulator of protein processing, trafficking, and degradation. While protein ubiquitination is utilized for many cellular processes, one major function of this system is to target proteins to the proteasome for degradation. In schizophrenia, studies have found UPS transcript abnormalities in both blood and brain, and we have previously reported decreased protein expression of ubiquitin-associated proteins in brain. To test whether the proteasome is similarly dysregulated, we measured the protein expression of proteasome catalytic subunits as well as essential subunits from proteasome regulatory complexes in 14 pair-matched schizophrenia and comparison subjects in superior temporal cortex...
February 2016: Neuropsychopharmacology: Official Publication of the American College of Neuropsychopharmacology
https://www.readbyqxmd.com/read/26169395/binding-of-sgta-to-rpn13-selectively-modulates-protein-quality-control
#10
Pawel Leznicki, Jelena Korac-Prlic, Katarzyna Kliza, Koraljka Husnjak, Yvonne Nyathi, Ivan Dikic, Stephen High
Rpn13 is an intrinsic ubiquitin receptor of the 26S proteasome regulatory subunit that facilitates substrate capture prior to degradation. Here we show that the C-terminal region of Rpn13 binds to the tetratricopeptide repeat (TPR) domain of SGTA, a cytosolic factor implicated in the quality control of mislocalised membrane proteins (MLPs). The overexpression of SGTA results in a substantial increase in steady-state MLP levels, consistent with an effect on proteasomal degradation. However, this effect is strongly dependent upon the interaction of SGTA with the proteasomal component Rpn13...
September 1, 2015: Journal of Cell Science
https://www.readbyqxmd.com/read/25914958/a-reversible-and-highly-selective-inhibitor-of-the-proteasomal-ubiquitin-receptor-rpn13-is-toxic-to-multiple-myeloma-cells
#11
Darci J Trader, Scott Simanski, Thomas Kodadek
The proteasome is a multisubunit complex responsible for most nonlysosomal turnover of proteins in eukaryotic cells. Proteasome inhibitors are of great interest clinically, particularly for the treatment of multiple myeloma (MM). Unfortunately, resistance arises almost inevitably to these active site-targeted drugs. One strategy to overcome this resistance is to inhibit other steps in the protein turnover cascade mediated by the proteasome. Previously, Anchoori et al. identified Rpn13 as the target of an electrophilic compound (RA-190) that was selectively toxic to MM cells (Cancer Cell 2013, 24, 791-805), suggesting that this subunit of the proteasome is also a viable cancer drug target...
May 20, 2015: Journal of the American Chemical Society
https://www.readbyqxmd.com/read/25747657/structural-plasticity-allows-uch37-to-be-primed-by-rpn13-or-locked-down-by-ino80g
#12
COMMENT
Xiang Chen, Kylie J Walters
Two studies in this issue of Molecular Cell,VanderLinden et al. (2015) and Sahtoe et al. (2015),report crystal structures that define how deubiquitinating enzyme UCH37 is switched on or off by proteasome ubiquitin receptor RPN13 or chromatin remodeler component INO80G.
March 5, 2015: Molecular Cell
https://www.readbyqxmd.com/read/25702872/structural-basis-for-the-activation-and-inhibition-of-the-uch37-deubiquitylase
#13
Ryan T VanderLinden, Casey W Hemmis, Benjamin Schmitt, Ada Ndoja, Frank G Whitby, Howard Robinson, Robert E Cohen, Tingting Yao, Christopher P Hill
The UCH37 deubiquitylase functions in two large and very different complexes, the 26S proteasome and the INO80 chromatin remodeler. We have performed biochemical characterization and determined crystal structures of UCH37 in complexes with RPN13 and NFRKB, which mediate its recruitment to the proteasome and INO80, respectively. RPN13 and NFRKB make similar contacts to the UCH37 C-terminal domain but quite different contacts to the catalytic UCH domain. RPN13 can activate UCH37 by disrupting dimerization, although physiologically relevant activation likely results from stabilization of a surface competent for ubiquitin binding and modulation of the active-site crossover loop...
March 5, 2015: Molecular Cell
https://www.readbyqxmd.com/read/25702870/mechanism-of-uch-l5-activation-and-inhibition-by-deubad-domains-in-rpn13-and-ino80g
#14
Danny D Sahtoe, Willem J van Dijk, Farid El Oualid, Reggy Ekkebus, Huib Ovaa, Titia K Sixma
Deubiquitinating enzymes (DUBs) control vital processes in eukaryotes by hydrolyzing ubiquitin adducts. Their activities are tightly regulated, but the mechanisms remain elusive. In particular, the DUB UCH-L5 can be either activated or inhibited by conserved regulatory proteins RPN13 and INO80G, respectively. Here we show how the DEUBAD domain in RPN13 activates UCH-L5 by positioning its C-terminal ULD domain and crossover loop to promote substrate binding and catalysis. The related DEUBAD domain in INO80G inhibits UCH-L5 by exploiting similar structural elements in UCH-L5 to promote a radically different conformation, and employs molecular mimicry to block ubiquitin docking...
March 5, 2015: Molecular Cell
https://www.readbyqxmd.com/read/25666615/the-e3-ubiquitin-ligase-parkin-is-recruited-to-the-26-s-proteasome-via-the-proteasomal-ubiquitin-receptor-rpn13
#15
Miguel A Aguileta, Jelena Korac, Thomas M Durcan, Jean-François Trempe, Michael Haber, Kalle Gehring, Suzanne Elsasser, Oliver Waidmann, Edward A Fon, Koraljka Husnjak
Mutations in the Park2 gene, encoding the RING-HECT hybrid E3 ubiquitin ligase parkin, are responsible for a common familial form of Parkinson disease. By mono- and polyubiquitinating target proteins, parkin regulates various cellular processes, including degradation of proteins within the 26 S proteasome, a large multimeric degradation machine. In our attempt to further elucidate the function of parkin, we have identified the proteasomal ubiquitin receptor Rpn13/ADRM1 as a parkin-interacting protein. We show that the N-terminal ubiquitin-like (Ubl) domain of parkin binds directly to the pleckstrin-like receptor for ubiquitin (Pru) domain within Rpn13...
March 20, 2015: Journal of Biological Chemistry
https://www.readbyqxmd.com/read/25318673/vwa-domain-of-s5a-restricts-the-ability-to-bind-ubiquitin-and-ubl-to-the-26s-proteasome
#16
Ravit Piterman, Ilana Braunstein, Elada Isakov, Tamar Ziv, Ami Navon, Shenhav Cohen, Ariel Stanhill
The 26S proteasome recognizes a vast number of ubiquitin-dependent degradation signals linked to various substrates. This recognition is mediated mainly by the stoichiometric proteasomal resident ubiquitin receptors S5a and Rpn13, which harbor ubiquitin-binding domains. Regulatory steps in substrate binding, processing, and subsequent downstream proteolytic events by these receptors are poorly understood. Here we demonstrate that mammalian S5a is present in proteasome-bound and free states. S5a is required for efficient proteasomal degradation of polyubiquitinated substrates and the recruitment of ubiquitin-like (Ubl) harboring proteins; however, S5a-mediated ubiquitin and Ubl binding occurs only on the proteasome itself...
December 15, 2014: Molecular Biology of the Cell
https://www.readbyqxmd.com/read/25306921/dss1-is-a-26s-proteasome-ubiquitin-receptor
#17
Konstantinos Paraskevopoulos, Franziska Kriegenburg, Michael H Tatham, Heike I Rösner, Bethan Medina, Ida B Larsen, Rikke Brandstrup, Kevin G Hardwick, Ronald T Hay, Birthe B Kragelund, Rasmus Hartmann-Petersen, Colin Gordon
The ubiquitin-proteasome system is the major pathway for protein degradation in eukaryotic cells. Proteins to be degraded are conjugated to ubiquitin chains that act as recognition signals for the 26S proteasome. The proteasome subunits Rpn10 and Rpn13 are known to bind ubiquitin, but genetic and biochemical data suggest the existence of at least one other substrate receptor. Here, we show that the phylogenetically conserved proteasome subunit Dss1 (Sem1) binds ubiquitin chains linked by K63 and K48. Atomic resolution data show that Dss1 is disordered and binds ubiquitin by binding sites characterized by acidic and hydrophobic residues...
November 6, 2014: Molecular Cell
https://www.readbyqxmd.com/read/24811749/autoubiquitination-of-the-26s-proteasome-on-rpn13-regulates-breakdown-of-ubiquitin-conjugates
#18
Henrike C Besche, Zhe Sha, Nikolay V Kukushkin, Andreas Peth, Eva-Maria Hock, Woong Kim, Steven Gygi, Juan A Gutierrez, Hua Liao, Lawrence Dick, Alfred L Goldberg
Degradation rates of most proteins in eukaryotic cells are determined by their rates of ubiquitination. However, possible regulation of the proteasome's capacity to degrade ubiquitinated proteins has received little attention, although proteasome inhibitors are widely used in research and cancer treatment. We show here that mammalian 26S proteasomes have five associated ubiquitin ligases and that multiple proteasome subunits are ubiquitinated in cells, especially the ubiquitin receptor subunit, Rpn13. When proteolysis is even partially inhibited in cells or purified 26S proteasomes with various inhibitors, Rpn13 becomes extensively and selectively poly-ubiquitinated by the proteasome-associated ubiquitin ligase, Ube3c/Hul5...
May 16, 2014: EMBO Journal
https://www.readbyqxmd.com/read/24752541/mechanism-of-the-rpn13-induced-activation-of-uch37
#19
Lianying Jiao, Songying Ouyang, Neil Shaw, Gaojie Song, Yingang Feng, Fengfeng Niu, Weicheng Qiu, Hongtao Zhu, Li-Wei Hung, Xiaobing Zuo, V Eleonora Shtykova, Ping Zhu, Yu-Hui Dong, Ruxiang Xu, Zhi-Jie Liu
Uch37 is a de-ubiquitinating enzyme that is activated by Rpn13 and involved in the proteasomal degradation of proteins. The full-length Uch37 was shown to exhibit low iso-peptidase activity and is thought to be auto-inhibited. Structural comparisons revealed that within a homo-dimer of Uch37, each of the catalytic domains was blocking the other's ubiquitin (Ub)-binding site. This blockage likely prevented Ub from entering the active site of Uch37 and might form the basis of auto-inhibition. To understand the mode of auto-inhibition clearly and shed light on the activation mechanism of Uch37 by Rpn13, we investigated the Uch37-Rpn13 complex using a combination of mutagenesis, biochemical, NMR, and small-angle X-ray scattering (SAXS) techniques...
2014: Protein & Cell
https://www.readbyqxmd.com/read/24429290/inherent-asymmetry-in-the-26s-proteasome-is-defined-by-the-ubiquitin-receptor-rpn13
#20
Dikla Berko, Ora Herkon, Ilana Braunstein, Elada Isakov, Yael David, Tamar Ziv, Ami Navon, Ariel Stanhill
The 26S double-capped proteasome is assembled in a hierarchic event that is orchestrated by dedicated set of chaperons. To date, all stoichiometric subunits are considered to be present in equal ratios, thus providing symmetry to the double-capped complex. Here, we show that although the vast majority (if not all) of the double-capped 26S proteasomes, both 19S complexes, contain the ubiquitin receptor Rpn10/S5a, only one of these 19S particles contains the additional ubiquitin receptor Rpn13, thereby defining asymmetry in the 26S proteasome...
February 28, 2014: Journal of Biological Chemistry
keyword
keyword
76270
1
2
Fetch more papers »
Fetching more papers... Fetching...
Read by QxMD. Sign in or create an account to discover new knowledge that matter to you.
Remove bar
Read by QxMD icon Read
×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"